MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
LDOS HOLD REF $109 PW TARGET $120 (+11% vs spot · 12m PWEV) +10% Single-name research · 8 July 2026
Equity ResearchIndustrials · Diversified Support Services
LDOS

Leidos Holdings Inc (LDOS)

HOLD. 12-month probability-weighted target $120 (+10% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

Verdict
HOLD
Triangulated fair value $105 (-4% vs spot · triangulated FV)
Reference
$109
Close · 8 July 2026
PW Target
$120 (+11% vs spot · 12m PWEV) +10%
Probability-weighted
Horizon
12 mo
MCH Advisory
$105 (-4% vs spot · triangulated FV)
Fair value
$120 (+11% vs spot · 12m PWEV)
Scenario PWEV
8.7x
Forward P/E
$14B
Market cap
$100–$204
52-week range
Contents

Rating: HOLD

HOLD (5-tier) · cyclical compounder · conviction: low

Metric Value
Current Price $109
Triangulated Fair Value $105 (-4% vs spot · triangulated FV)
12-mo Scenario PWEV $120 (+11% vs spot · 12m PWEV)
Forward P/E 8.7x
Market Cap $14B
52-Week Range $100–$204

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating HOLD · HOLD (5-tier)
Classification · conviction cyclical compounder · low
Triangulated fair value $105 (-4% vs spot · triangulated FV)
12-mo scenario PWEV $120 (+11% vs spot · 12m PWEV)
Next catalyst 2026-02-17 — FY guidance & book-to-bill / backlog update at annual results
Primary thesis-break Book-to-bill (trailing twelve months) < 1.0 (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies +11% vs spot
  • Monte Carlo median implies +0% vs spot
  • DCF fair value implies -15% vs spot — but this is terminal-value sensitive (exit-multiple $92 vs Gordon $190, 107% apart), so it carries less weight
  • Bear case (Structural — Defense-Budget Cuts / Aero-Production Halt) downside is -50% vs spot
  • Net: reward/risk of 0.1× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $102.97 Leidos trades on roughly 8x forward earnings and about 1.1x EV/revenue, a discount that prices in defence-budget stagnation and no margin progression. That is the market's implied view: a low-margin services book with limited pricing power and a continuing-resolution overhang. The engine's probability-weighted target of $124.40 differs by leaning on the DCF capex-D&A bridge, where trailing capex of $0.125bn sits below the modest forward glidepath, and on the base path converting a large backlog at ~5% growth with a 10.2% margin. The 5-anchor triangulation, not the peer screen, drives the read: the CTAS/CPRT peer multiples are structurally richer and are discounted rather than applied. A BUY and a $124.40 target follow because the probability-weighted earnings sit above what an 8x multiple capitalises, even after a 20% structural-impairment weight. The single most damaging risk is appropriations: a sequestration-style cut re-baselines firm-fixed-price programmes at a loss, compressing earnings and the multiple together, and pulls the target toward the mid-$50s.

The dashboard below is the whole argument on one page: spot ($109) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the <img src=
Integrated dashboard. The five valuation anchors bracket the $109 spot from $92 to $217 — fairly valued — spot brackets the blend.

Anti-Thesis (The Real Bear Case)

The highest-probability bear mechanism is the structural cut, carried at 20%. US defence discretionary spending is not guaranteed to grow: a debt-ceiling deal or a sequestration-style cap could freeze appropriations, and a prolonged continuing resolution starves new-start task orders while recompetes intensify. Leidos runs a thin ~10% margin on firm-fixed-price work, so a re-baselined programme or a lost recompete flows straight through. With net debt of $6.49bn, enlarged by the 2026Q1 acquisition outflow, a softer EBITDA path lifts leverage and curbs the buyback that has supported per-share earnings. In that state, revenue contracts, the margin compresses toward 8.5%, and the services multiple de-rates to trough. Earnings and the multiple fall together, and the target sits below the 52-week low.

Key Debate

Gross Margin explains 65% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.59 vs analyst floor +0.00 → delta +0.59 (n=20 mgmt / 12 Q&A; 87th pctile across the S&P book, z +1.2).

Flag: ELEVATED — management unusually upbeat vs the analyst floor relative to peers (disconfirmation watch).

Quarter Mgmt Analyst Delta
2026Q1 +0.59 +0.00 +0.59
2025Q4 +0.46 +0.22 +0.24
2025Q3 +0.59 +0.17 +0.41
2025Q2 +0.58 +0.15 +0.43

News (last 365d, 1000 articles): avg ticker sentiment +0.18 (bullish 29% / bearish 4%)

Scenario Analysis

The tree runs from a structural 'Structural — Defense-Budget Cuts / Aero-Production Halt' downside ($55) to a 'Bull — Re-Rate' bull case ($213); the probability-weighted blend (PWEV $120) is +11% versus spot.

Scenario Probability Target Return vs spot
Structural — Defense-Budget Cuts / Aero-Production Halt 20% $55 -50%
Cyclical Downturn — Air-Traffic / Program Recession 17% $89 -18%
Base — Backlog + Aftermarket 35% $125 +15%
Growth — Rearmament / Air-Traffic Recovery 20% $166 +53%
Bull — Re-Rate 8% $213 +96%
Probability-Weighted (PWEV) $120 +11%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Defense-Budget Cuts / Aero-Production Halt (20%, $55). Structural impairment — defense-budget cuts / aero-production halt: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 54.74; probability: 0.2.
  • Cyclical Downturn — Air-Traffic / Program Recession (17%, $89). Cyclical downturn — defense budgets + commercial-aero OE/aftermarket cycle + program execution weakens for 1–2 years before normalising. Drivers — implied_target: 92.95; probability: 0.17.
  • Base — Backlog + Aftermarket (35%, $125). Mid-cycle — normalised defense budgets + commercial-aero OE/aftermarket cycle + program execution; disciplined capital allocation; steady returns. Drivers — implied_target: 129.1; probability: 0.35.
  • Growth — Rearmament / Air-Traffic Recovery (20%, $166). Upside — rearmament + air-traffic recovery lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 174.28; probability: 0.2.
  • Bull — Re-Rate (8%, $213). Upside tail — sustained tight conditions or a structural re-rate on rearmament + air-traffic recovery. Drivers — implied_target: 220.11; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the <img src=
Five-scenario tree. Probability-weighted targets around the $109 spot; PWEV $120 (+11% vs spot · 12m). the payoff shows modest positive expectancy with material downside mass (range $55–$213)

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $109 +0%
Peer P/E re-rate multiple $217 +100%
Peer EV/Revenue re-rate multiple $534 +392%
Scenario PWEV multiple $120 +11%
DCF (5-year + terminal) cash flow + terminal × $92 -15%
Triangulated (weighted) $105 -4%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $109 and 50% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (65% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Monte Carlo distribution. Median <img src=
Monte Carlo distribution. Median $109; P(price > current) 50%. P10–P90: $41–$215.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.5%, 8x terminal FCF multiple → $92. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 8.5%, 8x terminal → $92.
Independent DCF. WACC 8.5%, 8x terminal → $92.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 17.46x) implies $217. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 17.46x → $217; EV/Rev re-rate → $534.
Cross-sectional peer benchmarking. Peer-median fwd P/E 17.46x → $217; EV/Rev re-rate → $534.

Across all anchors the spread is 368% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Aerospace & Defense $17.3B 100% 7% 10% $1.7B 10x 4% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver defense budgets + commercial-aero OE/aftermarket cycle + program execution
net_debt_or_cash_b -6.49

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.04
div_yield 0.0159

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside defense-budget cuts / aero-production halt
upside rearmament + air-traffic recovery

Industry Context — Ind Aero Defense

This name sits in the Ind Aero Defense as a aerospace_defense. defense budgets + commercial-aero OE/aftermarket cycle + program execution Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: GE (aerospace_defense) · RTX (aerospace_defense) · LMT (aerospace_defense) · HWM (aerospace_defense) · GD (aerospace_defense) · TDG (aerospace_defense) · NOC (aerospace_defense) · LHX (aerospace_defense) · AXON (aerospace_defense) · TXT (aerospace_defense) · LDOS (aerospace_defense) · HII (aerospace_defense)

Shared state Capex path House view This name implies
Defense-Budget Cuts / Aero-Production Halt 37% 37%
Mid-Cycle — Backlog + Aftermarket 35% 35%
Upside — Rearmament / Air-Traffic Recovery 28% 28%

Mapping note: name-level 'Structural — Defense-Budget Cuts / Aero-Production Halt' (20%) + 'Cyclical Downturn — Air-Traffic / Program Recession' (17%) map to cluster Defense-Budget Cuts / Aero-Production Halt (37%); name-level 'Growth — Rearmament / Air-Traffic Recovery' (20%) + 'Bull — Re-Rate' (8%) map to cluster Upside — Rearmament / Air-Traffic Recovery (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Defense-Budget Cuts / Aero-Production Halt () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The ind_aero_defense cycle is the shared macro driver. Driver — defense budgets + commercial-aero OE/aftermarket cycle + program execution Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $19B $2B $0B $0B $2B $1B
FY+2 $20B $2B $0B $0B $2B $1B
FY+3 $21B $2B $0B $0B $2B $1B
FY+4 $22B $2B $0B $0B $2B $1B
FY+5 $23B $2B $0B $0B $2B $1B
Terminal $2B × 8x $11B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.5% · Σ PV(FCF) $7B + PV(terminal) $11B = EV $18B; + net cash → equity $12B ÷ diluted shares 0.12B = $92/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $190/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 51% vs WACC 8% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
CTAS 6.45x 31.65x 6% 23%
CPRT 5.11x 17.83x 6% 38%
SWK 1.347x 17.09x 5% 6%
PNR 3.356x 13.99x 5% 23%
Median 4.2330000000000005x 17.46x

Peer-median fwd P/E → $217; EV/Rev → $534.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $92 47% $43
Scenario PWEV $120 33% $40
Monte Carlo median $109 20% $22
Triangulated 100% $105

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 5.6x 6.8x 8.0x 9.2x 10.4x
6% $75 $90 $104 $118 $132
8% $71 $84 $98 $111 $125
8% $66 $79 $92 $105 $118
10% $62 $74 $87 $99 $112
10% $58 $70 $82 $93 $105

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $40 $58 $75 $93 $111
-1.5pp $46 $65 $84 $103 $122
+0.0pp $52 $72 $92 $112 $133
+1.5pp $58 $80 $101 $123 $144
+3.0pp $65 $88 $111 $133 $156

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Op margin ±3pp $52 $133 $81
Revenue CAGR ±3pp $75 $111 $35
Terminal × ±15% $79 $105 $26
WACC ±1pp $87 $98 $11
Capex intensity ±15% $90 $94 $4

Company lever — SoP/share vs Aerospace & Defense multiple (AI re-rating) (base 10x)

Multiple 7.0x 8.5x 10.0x 11.5x 13.0x
SoP/share $924 $1,134 $1,343 $1,552 $1,761

Consensus & Market Expectations

Reference Value
Street target (mean) $168 (+55% vs spot · street)
House target $124 (-26.1% vs street)
Sell-side coverage 17 analysts (SB 3 / B 4 / H 10 / S 0 / SS 0; net score 0.29)
Consensus FY EPS $13.12; house below (-5.2%)
Consensus FY revenue $19.1B; house below (-3.1%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $4.7B — levered
Net debt / EBITDA 1.97x
Interest coverage (EBIT / interest) 10.4x
Current ratio 1.70x
Lease obligations $0.6B
Cash & ST investments $1.2B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $1.6B
Buybacks / dividends $0.9B / $0.2B
Total shareholder yield 8.5%
Payout as % of FCF 71.1%
Reinvestment (capex / OCF) 7.1%
SBC as % of FCF 5.8%
Allocation stance returns-heavy

Free-Cash-Flow Quality

Metric Value
FCF margin 9.4%
FCF conversion (FCF / net income) 112.2%
FCF yield 12.0%
Capex intensity (capex / revenue) 0.7%
FCF − SBC (diagnostic) $1.5B
Capex split (maint / growth) 75% / 25% — Services businesses are capital-light (~4% of revenue capex); most sustains facilities/IT while growth funds security-lab and product/IP investment. Maintenance-skewed.

Accounting quality: SBC 0.5% of revenue; cash conversion (OCF/NI) 121% — cash-backed.

Catalyst Calendar

  • 2026-02-17 (~-141d) — FY guidance & book-to-bill / backlog update at annual results (authored)
  • 2026-08-04 (~27d) — Quarterly earnings — est. EPS $2.91 (AV EARNINGS_CALENDAR)
  • 2026-09-30 (~84d) — US federal fiscal-year-end award/obligation cycle (continuing-resolution resolution) (authored)
  • 2027-04-01 (~267d) — Large recompete decisions on key IT-modernisation / health programs (authored)

Forecast Track Record

  • EPS surprise: beat 100.0% of the last 8 quarters; average surprise +16.4%.

Competitive Moat

Narrow moat. Leidos's moat is narrow — incumbency on long-tenor US government/defense IT and services contracts, security clearances and past-performance qualification create switching costs and high recompete win rates, but it is a low-margin cost-plus/services book with limited pricing power; a narrow moat supports roughly the ~8x forward multiple it trades at, and only a durable shift toward higher-margin digital/health and proprietary IP would justify a re-rate toward the mid-teens — absent that, budget stagnation warrants no premium to the low-double-digits.

Moat sources:

  • Incumbency and past-performance qualification on large multi-year federal contracts (recompete moat)
  • Facility/personnel security clearances as a barrier to entry
  • Scale as a top-tier US government services prime with broad agency relationships
  • Backlog (funded + unfunded) providing multi-year revenue visibility
Issue Probability Valuation sensitivity Horizon
US defense/civilian budget appropriations, continuing resolutions and DOGE-style efficiency cuts to services spend high (~55%) high - services outlays are a direct swing factor on revenue and awards; ~8% of FV 12-24m
Federal procurement/contracting reform, protest activity and margin caps on cost-plus work medium (~40%) medium - pressures already-thin services margins and award timing; ~4% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Defense-Budget Cuts / Aero-Production Halt A structural downshift in US federal/defense services spending (fiscal consolidation, efficiency mandates) permanently shrinks the addressable award pipeline. Backlog runs off faster than new awards replace it, driving revenue decline and margin deleverage.
Cyclical Downturn — Air-Traffic / Program Recession Cyclical program delays, CR-driven award slippage and a soft procurement cycle temporarily depress bookings. Book-to-bill falls below 1.0x for consecutive quarters, eroding forward revenue visibility.
Base — Backlog + Aftermarket Stable federal budgets; steady recompete wins and low-single-digit organic growth off a large funded backlog. Margin stays stuck at services-level lows with no mix improvement, leaving no path to a re-rate.
Growth — Rearmament / Air-Traffic Recovery Rising defense/national-security priorities plus digital-modernisation demand lift awards and shift mix toward higher-margin work. Awards concentrate in commoditised cost-plus scope, so revenue grows but margin fails to expand.
Bull — Re-Rate The market re-rates Leidos toward peer defense-tech multiples as digital/health mix and margin improve and budget certainty returns. A single large recompete loss or budget freeze reverses sentiment and reopens the discount.

What the Market Is Pricing In

At the current price, the market pays 8.3× forward EPS, vs the house DCF terminal 8.0×, and a peer median 17.46×. The house DCF sits 15% below spot, so the market is pricing in more than the house case — roughly 1.2pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Metric Consensus House Importance
Revenue 19.1 18.5 High
EPS 13.1 12.4 Medium
Target price 168.3 124.4 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
CTAS 31.65× 6% 23% broad 25%
CPRT 17.83× 6% 38% broad 25%
SWK 17.09× 5% 6% broad 25%
PNR 13.99× 5% 23% broad 25%

Quality-weighted forward P/E: 20.1× (simple median 17.46×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $100–$204, centre $143 (+31% vs spot); spot sits at the 9th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $105 (-4% vs spot · triangulated FV)
Downside to bear case (Structural — Defense-Budget Cuts / Aero-Production Halt) $55 (-50% vs spot · bear scenario)
Reward/risk ratio 0.1×
Margin of safety (FV vs spot) -4%
P(price > spot) — Monte Carlo 50%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $213.

Assumption Register

Assumption Value Used in Source
WACC 8.5% DCF discount rate estimate (CAPM)
Terminal multiple DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (81.0); Revenue CAGR ±3pp (35.0); Terminal × ±15% (26.0); WACC ±1pp (11.0); Capex intensity ±15% (4.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $17.3B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $18.5B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $13.1246 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.125B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $4.725B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 8.5% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-27
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 8%, terminal multiple 8×, FY+5 revenue $23B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Book-to-bill (trailing twelve months) < 1.0 (2 consecutive prints → Defense-Budget Cuts / Aero-Production Halt). Sub-1.0 TTM book-to-bill for two quarters signals backlog erosion and undercuts the mid-single-digit organic growth the base case converts.
  • Organic revenue growth (year-on-year) < 0.015 (2 consecutive prints → Mid-Cycle — Backlog + Aftermarket). Midpoint between the base (5% growth) and cyclical (minus 2%) paths; two prints below 1.5% place the book on the cyclical-downturn track rather than the base case.
  • Non-GAAP operating margin < 0.099 (2 consecutive prints → Mid-Cycle — Backlog + Aftermarket). Midpoint of the base (10.2%) and cyclical (9.6%) margin paths; sustained margin below 9.9% indicates fixed-cost deleverage or programme re-baselining rather than mix noise.
  • Net debt / EBITDA > 3.5 (2 consecutive prints → Defense-Budget Cuts / Aero-Production Halt). The 2026Q1 investing outflow (-$2.36bn) reflects a debt-funded acquisition; leverage above 3.5x while EBITDA softens constrains buybacks and raises refinancing risk given the -$6.49bn net-debt position.
  • Free cash flow conversion (FCF / adjusted net income) < 0.9 (2 consecutive prints → Mid-Cycle — Backlog + Aftermarket). Services economics depend on high cash conversion; two prints below 90% would signal working-capital strain or unbilled-receivable build that erodes the shareholder-return capacity underpinning the base case.

Fact / Inference / Speculation

  • FACT: Spot $109; 52-week range $100–$204; engine rating HOLD; base-case target $124 (+15%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
  • INFERENCE: Triangulated FV $105 (-4% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that Gross Margin keeps surprising favourably — an operating call the next two prints will test.

Recommendation: HOLD

Balanced: triangulated fair value $118 (+9% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin — a fundamental call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.